Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05360849 · ClinicalTrials.gov registry record · NA
Implementing PrEP for Women Who Inject Drugs
A NA study, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT05360849: Active NA study, sponsored by University of Pennsylvania.
NCT05360849 is a NA study that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05360849, a NA study, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
Women who inject drugs are among the most vulnerable to acquiring HIV, but very few women who inject drugs are prescribed pre-exposure prophylaxis (PrEP) for HIV prevention largely due to barriers within our healthcare system. This research will consider the perspectives of women who inject drugs, healthcare providers, and clinic leadership to improve the way primary care and reproductive health clinics deliver PrEP to women who inject drugs, thereby reducing new HIV infections in this population.
Interventions
- BEHAVIORAL Practice Facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2021-06-22 |
| Est. Completion | 2027-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05360849
The ClinicalTrials.gov registry entry for NCT05360849 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Practice Facilitation is the first listed.
NCT05360849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05360849 about?
NCT05360849 is a clinical study titled "Implementing PrEP for Women Who Inject Drugs". Women who inject drugs are among the most vulnerable to acquiring HIV, but very few women who inject drugs are prescribed pre-exposure prophylaxis (PrEP) for HIV prevention largely due to barriers within our healthcare system. This research will consider the perspectives of women who inject drugs, h...
What is the current status of trial NCT05360849?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2021-06-22. Estimated completion is 2027-03-24.
What interventions are being tested in trial NCT05360849?
The interventions under investigation include: Practice Facilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05360849?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.